XML 99 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Discontinued Operations (Tables)
 12 Months Ended
Mar. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]  
Summary Of Disposal Groups Including Discontinued Operations Income Statement
The following table presents components of discontinued operations included in “Income from discontinued operations, net of tax” for the year ended March 31, 2020 (in thousands).
 
    
Year Ended
March 31, 2020
  
Operating expenses:
         
Research and development
    $ 265,452  
General and administrative
      119,885  
    
 
 
  
Total operating expenses
      385,337  
    
 
 
  
Loss from operations
      (385,337 ) 
    
 
 
  
Gain on sale of business
      (1,985,949 ) 
Interest income
      (2,305 ) 
Interest expense
(1)
      13,733  
Other expense
      8,866  
    
 
 
  
Income from discontinued operations before income taxes
      1,580,318  
Income tax expense
      1,892  
    
 
 
  
Income from discontinued operations, net of tax
    $ 1,578,426  
    
 
 
  
Loss from discontinued operations before income taxes attributable to noncontrolling interests
    $ (141,783 ) 
Income from discontinued operations before income taxes attributable to Roivant Sciences Ltd.
      1,722,101  
    
 
 
  
Income from discontinued operations before income taxes
    $ 1,580,318  
    
 
 
  
 
(1)
 
Interest expense consists of interest payments related to outstanding debt held by Myovant and Urovant as well as the associated
non-cash
amortization of debt discounts and issuance costs.
Summary of Cash Flows from Discontinued Operations The significant cash flow items from discontinued operations were as follows (in thousands):
    
Year Ended
March 31, 2020
  
Gain on sale of business
    $ (1,985,949 ) 
Share-based compensation
    $ 54,821  
Acquired
in-process
research and development
    $ 16,405